An International Observational Prospective Study On Long-Term Response To Botulinum Toxin Type A (BoNT-A) Injections In Subjects Suffering From Idiopathic Cervical Dystonia (CD) - Pharmaco-Economic Impact
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 31 Aug 2017
At a glance
- Drugs Botulinum toxin A (Primary)
- Indications Torticollis
- Focus Therapeutic Use
- Acronyms INTEREST IN CD2
- Sponsors Ipsen
- 28 Aug 2017 Planned End Date changed from 1 Jul 2017 to 1 Sep 2017.
- 28 Aug 2017 Planned primary completion date changed from 1 Jul 2017 to 1 Sep 2017.
- 08 Jun 2017 Results (n=966) assessing the impact of regional differences on the drivers for change in TWSTRS total score, presented at the 21st International Congress of Parkinson's Disease and Movement Disorders